NCT01854788

Brief Summary

Study design: a randomized, crossover trial. Each patient performed three different airway clearance techniques (Autogenic drainage, slow expiratory with glottis opened in lateral posture \[ELTGOL\], temporary- positive expiratory pressure \[T-PEP\] with not similar autonomy degree in a randomized order. Each technique were applied in 3 sessions during one week at alternate days (Monday /Wednesday/Friday or Tuesday/Thursday/Saturday). The time spent in each bronchial session was 40 minutes. Seven days were the wash-out time period between the different techniques.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2012

Completed
9 months until next milestone

First Posted

Study publicly available on registry

May 16, 2013

Completed
Last Updated

May 16, 2013

Status Verified

May 1, 2013

Enrollment Period

1.8 years

First QC Date

August 8, 2012

Last Update Submit

May 13, 2013

Conditions

Keywords

Airway clearance techniquesMucus clearanceChest physiotherapyAutogenic drainageSlow expiration with glottis opened in lateral posture(ELTGOL)Temporary-positive expiratory pressure (T-PEP)Non cystic fibrosis bronchiectasis

Outcome Measures

Primary Outcomes (2)

  • Weight of sputum expectorated during each airway clearance therapy session

    Wet weight sputum production were recollected in one pre-weighted containers. It was measured in grams.

    40 minutes

  • Weight of sputum expectorated 24 hours post each bronchial session

    Wet weight sputum production were recollected in one pre-weighted containers. It was measured in grams.

    24 hours

Secondary Outcomes (2)

  • Saint George Respiratory Questionnaire (SGRQ)

    Change from baseline at 5 weeks

  • Leicester Cough Questionnaire (LCQ)

    Changes from baseline arm to 1 week

Other Outcomes (2)

  • Lung function measured by simple spirometry: forced expiratory volume in 1 second, Forced vital capacity, Forced expiratory flow 25-75

    Change from baseline arm to 1 week

  • Likert test

    Change from baseline arm to 1 week

Study Arms (3)

Autogenic drainage

ACTIVE COMPARATOR

All patients performed all interventions in a randomized order. Each technique was applied in 3 non consecutively sessions during one week. The time spent during the session was 40 minutes

Other: Autogenic drainage

Slow expiration with glottis opened in lateral posture

ACTIVE COMPARATOR

All patients performed all interventions in a randomized order.Each technique was applied in 3 non consecutively sessions during one week. The time spent during the session was 40 minutes

Other: Slow expiration with glottis opened in lateral posture

Temporary-Positive Expiratory Pressure

ACTIVE COMPARATOR

All patients performed all interventions in a randomized order. Each technique was applied in 3 non consecutively sessions during one week. The time spent during the session was 40 minutes

Other: Temporary-positive expiratory pressure

Interventions

It was performed following J. Chevallier recommendations.In this trial it was considered a self-administrated technique because physiotherapist only gave oral advice in order to ensure a correct performance of the technique.

Autogenic drainage

It was performed following Postiaux´s recommendations. In this trial the technique was considered active-assisted because the physiotherapy played a role important in their execution.

Also known as: Slow expiratory with glotis opened in lateral position
Slow expiration with glottis opened in lateral posture

The diaphragmatic breathing was required for this technique whereas patients remain seated in front of the device with a nose clip. The inspiratory /expiratory ratio was 1:2.It was taken into account as a device-administrated technique for this trial.

Temporary-Positive Expiratory Pressure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Non Cystic Fibrosis bronchiectasis diagnosed by High Resolution Computed Tomographic
  • \- Mean sputum production ≥ 15 ml /24h
  • \- Clinical stability in the last 6 weeks
  • \- Not carrying out regular chest physiotherapy
  • \- Forced expiratory volume in 1 second ≥ 30% pred. ; Forced Vital Capacity ≥ 45% pred. and peak expiratory flow \>270 L/s

You may not qualify if:

  • \- Smoker or non-smoker form less than 2 years
  • \- Cystic fibrosis
  • \- Active tuberculosis or sarcoidosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital CLinic

Barcelona, Barcelona, 08029, Spain

Location

Related Publications (2)

  • Herrero-Cortina B, Alcaraz-Serrano V, Torres A, Polverino E. Reliability and Minimum Important Difference of Sputum Weight in Bronchiectasis. Respir Care. 2020 Oct;65(10):1478-1487. doi: 10.4187/respcare.07175. Epub 2020 Feb 18.

  • Herrero-Cortina B, Vilaro J, Marti D, Torres A, San Miguel-Pagola M, Alcaraz V, Polverino E. Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy. 2016 Dec;102(4):357-364. doi: 10.1016/j.physio.2015.07.005. Epub 2015 Dec 1.

MeSH Terms

Conditions

Bronchiectasis

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract Diseases

Study Officials

  • Beatriz Herrero, Phy

    Hospital Clinic of Barcelona

    PRINCIPAL INVESTIGATOR
  • Eva Polverino, Doctor

    Hospital Clinic of Barcelona

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

August 8, 2012

First Posted

May 16, 2013

Study Start

September 1, 2010

Primary Completion

June 1, 2012

Study Completion

August 1, 2012

Last Updated

May 16, 2013

Record last verified: 2013-05

Locations